In FDA REcalls on May 30, 2013 at 6:41 pm
The fungal meningitis tragedy is still ongoing.
An 80-year-old Virginia man, discharged after more than 4 months of therapy, relapsed and needed additional treatment less than a month after discharge, according to Rachel Smith, MD, of the CDC, and colleagues at the agency and in Virginia.
The case illustrates the possibility of relapse despite lengthy therapy and resolution of signs and symptoms, Smith and colleagues reported online in the New England Journal of Medicine.
On the other hand, they noted, the CDC knows of similar patients who have not relapsed after stopping antifungal therapy but “the risk of relapse should be considered” when doctors decide to discontinue treatment.
The outbreak started in late September, 2012, when Tennessee doctors began treating a man for an unusual form of meningitis that did not seem to have a bacterial or viral cause.
Eventually, they found evidence of a fungal infection — with the mold Aspergillus fumigatus – and notified the state’s public health authorities.
In Uncategorized on May 26, 2013 at 12:49 am
The Alabama Department of Public Health is working with other health agencies to investigate an injectable anti-inflammatory drug prepared by a compounding manufacturer in Tennessee.
Main Street Family Pharmacy of Newbern, Tenn. shipped the tainted medicine to clinics in 13 states, including to one clinic in Alabama.
The investigation began after the U.S. Food and Drug Administration was notified of seven people who developed infections or adverse reactions after receiving injections of methylprednisolone acetate (MPA). It’s the same drug that was linked to last year’s deadly outbreak of fungal meningitis.
The investigation is in an early stage and is rapidly evolving, according to Dr. Mary McIntyre of the ADPH.
The Alabama clinic will begin notifying patients to ask them to report any signs and symptoms of complications.
In Uncategorized on May 26, 2013 at 12:17 am
Federal authorities have identified five cases in Illinois and two more in North Carolina. The Illinois patients received injections at the Logan Primary Care clinic in the town of Herrin between Jan. 3 and Feb. 21, according to Illinois health officials.
All five patients from Illinois had skin infections in the hips and buttocks while at least one patient in North Carolina appears to have a fungal infection, according to the Centers for Disease Control and Prevention.